IDF21-0453 Phase-3 active control trial to evaluate Safety and Efficacy of Repaglinide plus Voglibose combination in T2D patients. (April 2022)

Record Type:: Journal Article
Title:: IDF21-0453 Phase-3 active control trial to evaluate Safety and Efficacy of Repaglinide plus Voglibose combination in T2D patients. (April 2022)
Main Title:: IDF21-0453 Phase-3 active control trial to evaluate Safety and Efficacy of Repaglinide plus Voglibose combination in T2D patients
Authors:: Chawla, M.S.
Sahoo, A.K.
Ramanathan, B.
Dhand, S.
Parikh, D.
Rathod, D.
Gupta, R.
Kavathiya, K.
Korukonda, K.
Abstract:
Is Part Of:: Diabetes research and clinical practice. Volume 186:Supplement 1(2022)
Journal:: Diabetes research and clinical practice
Issue:: Volume 186:Supplement 1(2022)
Issue Display:: Volume 186, Issue 1 (2022)
Year:: 2022
Volume:: 186
Issue:: 1
Issue Sort Value:: 2022-0186-0001-0000
Page Start:
Page End:
Publication Date:: 2022-04
Subjects:: Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462
Journal URLs:: http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.diabres.2022.109545 ↗
Languages:: English
ISSNs:: 0168-8227
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21917.xml